Nabil Angelozzi-Amirouchene

Milan, 20139, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Evolving neoantigen profiles in colorectal cancers with DNA repair defects.

Evolving neoantigen profiles in colorectal cancers with DNA repair defects.

Journal: Genome medicine
Published: January 17, 2019

The Clinical Impact of the Genomic Landscape of Mismatch Repair-Deficient Cancers.

The Clinical Impact of the Genomic Landscape of Mismatch Repair-Deficient Cancers.

Journal: Cancer discovery
Published: February 19, 2018

Tumor Evolution as a Therapeutic Target.

Tumor Evolution as a Therapeutic Target.

Journal: Cancer discovery
Published: March 30, 2017

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

Journal: Nature
Published: May 03, 2016

Upcoming translational challenges for uveal melanoma.

Upcoming translational challenges for uveal melanoma.

Journal: British journal of cancer
Published: December 24, 2015

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.

Journal: Oncotarget
Published: October 06, 2015

Upcoming translational challenges for uveal melanoma.

Upcoming translational challenges for uveal melanoma.

Journal: British journal of cancer
Published: April 01, 2015

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Journal: Molecular oncology
Published: February 10, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026